In the News

Our CEO – Linda Cahn – is a nationally recognized expert who is often contacted and quoted by the press. Immediately below we attach a list of articles quoting Linda – or describing drug analyses generated and disseminated by our firm – beginning with the most recent. We also provide a list of periodicals, enabling you to review articles carried by specific journals. Many of these articles provide useful information about key topics. We hope you will find them to be of assistance.

Federal PBM probe culminates decades of M&A

Federal PBM probe culminates decades of M&A

By Nona Tepper and Maya Goldman, June 14, 2022

Read More
Federal PBM Probe Culminates Decades of M&A

Federal PBM Probe Culminates Decades of M&A

By Nona Tepper and Maya Goldman, June 14, 2022

Read More
Kansas audited its $80 million CVS prescription plan, but it’s still shrouded in mystery

Kansas audited its $80 million CVS prescription plan, but it’s still shrouded in mystery

By Celia Llopis-Jansen, October, 1, 2021.

Read More
Expert Warns: Ohio Medicaid Poised for Big Trouble

Expert Warns: Ohio Medicaid Poised for Big Trouble

By Marty Schladen, August 27, 2020

Read More
New ‘Transparent’ Setup for Medicaid Drug Purchase will be Secret to Public

New ‘Transparent’ Setup for Medicaid Drug Purchase will be Secret to Public

By Marty Schladen. April 18, 2019.

Read More
More Sunshine, Say Some PBM Forecasts. More of the Dark Arts, Say Others.

More Sunshine, Say Some PBM Forecasts. More of the Dark Arts, Say Others.

By Robert Calandra. March 1, 2019.

Read More
‘PBM Busters’ Find Employers Unaware of Price Mark-Ups By Drug Middlemen

‘PBM Busters’ Find Employers Unaware of Price Mark-Ups By Drug Middlemen

By Lucas Sullivan. December 24, 2018.

Read More
CVS Caremark Wants To Make Drug Rebates a Thing of the Past

CVS Caremark Wants To Make Drug Rebates a Thing of the Past

December 6, 2018.

Read More
CVS Boasts That A New Pricing Model Will Lower Drug Costs For Health Plans. Will It?

CVS Boasts That A New Pricing Model Will Lower Drug Costs For Health Plans. Will It?

By Ed Silverman. December 5, 2018.

Read More
FDA Promised a ‘Lower-Cost Option’ to Epi-Pen, But the Price Isn’t Any Lower

FDA Promised a ‘Lower-Cost Option’ to Epi-Pen, But the Price Isn’t Any Lower

By Ed Silverman. November 27, 2018.

Read More
What Rebates? Express Scripts Touts A New Plan To Appease Critics Of The Opaque Drug-Pricing System

What Rebates? Express Scripts Touts A New Plan To Appease Critics Of The Opaque Drug-Pricing System

By Ed Silverman. November 13, 2018.

Read More
More States, Including Pa., Are Taking On Pharmacy Benefit Managers, Demanding To See the Savings In Medicaid

More States, Including Pa., Are Taking On Pharmacy Benefit Managers, Demanding To See the Savings In Medicaid

By Catherine Dunn. November 9, 2018.

Read More
The Unclear Benefits of Drug Price Coalitions

The Unclear Benefits of Drug Price Coalitions

By Bob Herman. September 27, 2018.

Read More
Never Mind the Rebates. Maybe Behind-the-Scenes Fees Are Boosting Drug Prices

Never Mind the Rebates. Maybe Behind-the-Scenes Fees Are Boosting Drug Prices

By Ed Silverman. August 16, 2018.

Read More
In Prescription Drug Business, Will Amazon Partner with PBMs, Or Seek to Conquer Them?

In Prescription Drug Business, Will Amazon Partner with PBMs, Or Seek to Conquer Them?

By Casey Ross. July 16, 2018.

Read More
Ohio Peels Back The Curtain On A Lucrative PBM Profit Center

Ohio Peels Back The Curtain On A Lucrative PBM Profit Center

By Ed Silverman. June 22, 2018.

Read More
What New Jersey’s Drug Plan Do-Over Says About the Industry

What New Jersey’s Drug Plan Do-Over Says About the Industry

By Bob Herman. May 16, 2018.

Read More
Drug prices continue to climb despite barrage of criticism

Drug prices continue to climb despite barrage of criticism

By Angelica LaVito. March 21, 2018.

Read More
UnitedHealthcare will pass some rebates to consumers, but will this really lower drug prices?

UnitedHealthcare will pass some rebates to consumers, but will this really lower drug prices?

By Ed Silverman. March 6, 2018.

Read More
Washington is taking aim at drug industry middlemen. But can it break their grip on a captive market?

Washington is taking aim at drug industry middlemen. But can it break their grip on a captive market?

By Casey Ross. February 16, 2018.

Read More
Long-Dreaded Amazon Threat to Drug Middlemen Draws Closer

Long-Dreaded Amazon Threat to Drug Middlemen Draws Closer

By Robert Langreth and Zachary Taylor. January 30, 2018.

Read More
PBMs: Will the Amazon Cometh?

PBMs: Will the Amazon Cometh?

By Robert Calandra. December 1, 2017.

Read More
Congress Needs the Political Courage to Defy the Drug Manufacturer Lobby

Congress Needs the Political Courage to Defy the Drug Manufacturer Lobby

Linda Cahn, Op-Ed Contributor. November 17, 2017.

Read More
Hey, Amazon: As a pharmacy benefit manager, you could create real competition for drug prices

Hey, Amazon: As a pharmacy benefit manager, you could create real competition for drug prices

Op-Ed by Linda Cahn. November 15, 2017.

Read More
Time to Lift the Curtain on PBM Wheeling and Dealing

Time to Lift the Curtain on PBM Wheeling and Dealing

by Robert Calandra.

Read More
How Two Common Medications Became One $455 Million Specialty Pill

How Two Common Medications Became One $455 Million Specialty Pill

by Marshall Allen. June 20, 2017.

Read More
How Two Common Medications Became One $455 Million Specialty Pill

How Two Common Medications Became One $455 Million Specialty Pill

by Marshall Allen. June 20, 2017.

Read More
Q&A (with Linda Cahn): Pharma and PBMs are in a ‘Two Step Dance’ that Raises Drug Prices

Q&A (with Linda Cahn): Pharma and PBMs are in a ‘Two Step Dance’ that Raises Drug Prices

by Ed Silverman. June 13, 2017.

Read More
How ‘Price-Cutting’ Middlemen Are Making Crucial Drugs Vastly More Expensive

How ‘Price-Cutting’ Middlemen Are Making Crucial Drugs Vastly More Expensive

by Michael Hiltzik. June 9, 2017.

Read More
No Quick Cure for Express Scripts’ Ailing Shares

No Quick Cure for Express Scripts’ Ailing Shares

by Bill Alpert. June 5, 2017.

Read More
A Drug Quintupled in Price. Now, Drug Industry Players Are Feuding Over the Windfall

A Drug Quintupled in Price. Now, Drug Industry Players Are Feuding Over the Windfall

by Charles Orenstein and Katie Thomas. June 1, 2017.

Read More
Express Scripts Sues Manufacturer of Overdose Treatments

Express Scripts Sues Manufacturer of Overdose Treatments

by Angela Mueller. June 2017.

Read More
Express Scripts Sues Maker of Overdose Drug, Intensifying Feud

Express Scripts Sues Maker of Overdose Drug, Intensifying Feud

by Katie Thomas and Charles Orenstein. May 31, 2017.

Read More
A Drug Quintupled in Price. Now, Drug Industry Players Are Feuding Over the Windfall

A Drug Quintupled in Price. Now, Drug Industry Players Are Feuding Over the Windfall

by Charles Orenstein and Katie Thomas. May 31, 2017.

Read More
Would Amazon Really Succeed As A Pharmacy Benefit Manager?

Would Amazon Really Succeed As A Pharmacy Benefit Manager?

by Ed Silverman. May 18, 2017.

Read More
Drug Company Says Discount Program Will Lower Prescription Prices

Drug Company Says Discount Program Will Lower Prescription Prices

Dayton Daily News. May 11, 2017.

Read More
Express Scripts and Some Drug Makers Say They Can Work Together To Lower Costs

Express Scripts and Some Drug Makers Say They Can Work Together To Lower Costs

by Ed Silverman. May 8, 2017.

Read More
Inside the ‘Scorpion Room’ Where Drug Price Secrets Are Guarded

Inside the ‘Scorpion Room’ Where Drug Price Secrets Are Guarded

by Neil Weinberg and Robert Langreth. May 4, 2017.

Read More
A Secret Profit Formula Loved by Drug Middlemen Is At Risk

A Secret Profit Formula Loved by Drug Middlemen Is At Risk

by Robert Langreth and Neil Weinberg. April 26, 2017.

Read More
The Hidden Monopolies That Raise Drug Prices: How Pharmacy Benefit Managers Morphed From Processors to Predators

The Hidden Monopolies That Raise Drug Prices: How Pharmacy Benefit Managers Morphed From Processors to Predators

by David Dayen. April 3, 2017.

Read More
Spread Pricing – Marking Up Drug Claims

Spread Pricing – Marking Up Drug Claims

As featured on The National Community Pharmacists Association (www.ncpanet.org).

Read More
A New Senate Bill Would Require PBMs to Disclose Some Rebate Info

A New Senate Bill Would Require PBMs to Disclose Some Rebate Info

by Ed Silverman. March 15, 2017.

Read More
Drug Costs Too High: Fire the Middlemen

Drug Costs Too High: Fire the Middlemen

by Neil Weinberg and Robert Langreth. March 3, 2017.

Read More
For E.D., The Doctor is In But the Men Are Staying Away: Physicians Find Men Lack Interest In Seeking Medical Care If They Can’t Get Coverage for Erectile Dysfunction

For E.D., The Doctor is In But the Men Are Staying Away: Physicians Find Men Lack Interest In Seeking Medical Care If They Can’t Get Coverage for Erectile Dysfunction

by Joseph Burns.

Read More
Pharmacy Benefit Managers Could Be In Legislative Crosshairs

Pharmacy Benefit Managers Could Be In Legislative Crosshairs

by Christian Britschgi. January 3, 2017.

Read More
The ‘Gouge Factor’: Big Companies Want Transparency In Drug Price Negotiations

The ‘Gouge Factor’: Big Companies Want Transparency In Drug Price Negotiations

by Ed Silverman. August 2, 2016.

Read More
Pharmacy Benefit Managers Under Pressure

Pharmacy Benefit Managers Under Pressure

by Bill Alpert. Cover Story, July 23, 2016.

Read More
Pharmacy Managers Unleash Big Data

Pharmacy Managers Unleash Big Data

by Zachary Tracer. June 30, 2016.

Read More
Drug Spending Increase Slowed to 5.2 Percent Last Year, Express Scripts Says

Drug Spending Increase Slowed to 5.2 Percent Last Year, Express Scripts Says

by Ed Silverman. March 14, 2016.

Read More
Secret Deals May Mean Consumers Pay More For Drugs

Secret Deals May Mean Consumers Pay More For Drugs

by Jayne O’Donnell. March 22, 2016.

Read More
Feds Call Prescription Drug Price 2014 Increase ‘Remarkable’

Feds Call Prescription Drug Price 2014 Increase ‘Remarkable’

by Jayne O’Donnell. March 8, 2016.

Read More
An Rx for Specialty Drug Management: Key to Success Lies in Better PBM Contracts, Plan Design Tweaks

An Rx for Specialty Drug Management: Key to Success Lies in Better PBM Contracts, Plan Design Tweaks

by Bruce Shutan. October 2015.

Read More
Prescription Coalition Leader Warns About Increased Rx Costs From PBMs’ Refill Practices

Prescription Coalition Leader Warns About Increased Rx Costs From PBMs’ Refill Practices

as featured on StreetInsider.com

Read More
Drug Coupons Not Good For Patients Either

Drug Coupons Not Good For Patients Either

as seen on Managed Care Magazine.

Read More
Painful Prescription

Painful Prescription

by Katherine Eban. October 28, 2013.

Read More
News Roundup: December 2012

News Roundup: December 2012

by Adam Fein. December 18, 2012.

Read More
Buzz Words Collide With Positive Results

Buzz Words Collide With Positive Results

by John Marcille.

Read More
In Plain View: Linda Cahn Makes The Case for PBM Fee Disclosure

In Plain View: Linda Cahn Makes The Case for PBM Fee Disclosure

by Molly Bernhart. Cover Story – May 2008.

Read More
Amazon is Headed for the Prescription Drug Market, Analysis Say,

Amazon is Headed for the Prescription Drug Market, Analysis Say,

Robert Langreth and Spencer Soper. October 6, 2007.

Read More
Medco Health’s ‘Aggravating’ Case: A Setback on a Class-Action Settlement Could Nettle the Big Pharmacy, Observers Say

Medco Health’s ‘Aggravating’ Case: A Setback on a Class-Action Settlement Could Nettle the Big Pharmacy, Observers Say

by Melissa Davis. December 16, 2005.

Read More
Appeals Court Orders A Review of Medco Settlement Challenge

Appeals Court Orders A Review of Medco Settlement Challenge

By Mil Freudenheim. December 13, 2005.

Read More
U.S. Accuses Merck Unit of Cheating Health Plan

U.S. Accuses Merck Unit of Cheating Health Plan

By Milt Freudenheim. June 24, 2003.

Read More
Merck to Pay $42.5 Million to Settle Lawsuits Against Its Pharmacy-Benefit Unit

Merck to Pay $42.5 Million to Settle Lawsuits Against Its Pharmacy-Benefit Unit

By Milt Freudenheim. December 10, 2002.

Read More